Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07209254 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
A NA study of Hypertension, Pregnancy Induced, sponsored by Jennifer Lewey, MD, MPH.
- Recruiting
- Registry status
- NA
- Development phase
- 770
- Enrollment target
- 3
- Study locations
NCT07209254: Recruiting NA study of Hypertension, Pregnancy Induced, sponsored by Jennifer Lewey, MD, MPH.
NCT07209254 is a NA study of Hypertension, Pregnancy Induced that is actively recruiting participants, run by Jennifer Lewey, MD, MPH. The registered enrollment target is 770 participants, above the 216-participant average among 7 other Hypertension, Pregnancy Induced trials with a reported enrollment target (256% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07209254, a NA study of Hypertension, Pregnancy Induced, is actively recruiting participants, sponsored by Jennifer Lewey, MD, MPH.
- RECRUITING
- Registry status
- NA
- Development phase
- 770 participants
- Enrollment target
- 3
- Study locations
Study Summary
A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's health
Primary Outcome
Assessed by 24-hour ambulatory blood pressure monitor (ABPM)
Conditions Studied
Interventions
- OTHER High-touch blood pressure management
- OTHER Low-touch blood pressure management
Study Locations (3)
New York
- New York University - New York
Ohio
- The Ohio State University - Columbus
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 770 participants |
| Start Date | 2026-03-02 |
| Est. Completion | 2029-11 |
| Phase | NA |
What NCT07209254 shows while recruiting
NCT07209254 is an interventional study that assigns participants to a tested intervention. The registered 770 participants enrollment target is mid-sized for trials with a published cap, above the 216-participant average among 7 other Hypertension, Pregnancy Induced trials with a reported enrollment target (256% higher).
The record links to 1 condition, with Hypertension, Pregnancy Induced appearing as the primary indexed condition, and to 2 interventions - of which High-touch blood pressure management is the first listed.
NCT07209254 reports a single indexed study location in New York, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07209254 about?
NCT07209254 is a clinical study titled "Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension". A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's health
What is the current status of trial NCT07209254?
This trial is currently recruiting. It is a NA study. The enrollment target is 770 participants. The study started on 2026-03-02. Estimated completion is 2029-11.
What conditions does trial NCT07209254 study?
This clinical trial studies the following conditions: Hypertension, Pregnancy Induced.
What interventions are being tested in trial NCT07209254?
The interventions under investigation include: High-touch blood pressure management (OTHER), Low-touch blood pressure management (OTHER).
Who is sponsoring clinical trial NCT07209254?
This trial is sponsored by Jennifer Lewey, MD, MPH, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07209254 being conducted?
This trial has 3 study locations across New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension, Pregnancy Induced
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
RECRUITING · NA
-
Better Understanding Patient Perspectives of an Educational Tool for Postpartum Hypertensive Patients
ACTIVE NOT RECRUITING · NA
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05977348 · 770 participants · NA
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
- NCT06376994 · 770 participants · Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
- NCT06824467 · 770 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- NCT06907173 · 770 participants · Phase 3
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI